Mean change in best corrected visual acuity (BCVA) as assessed by the number of letters read correctly on the ETDRS eye chart at a starting test distance of 4 meters from baseline to Month 6. Baseline to Month 6. [clinicaltrials_resource:7aea4f643111e1e688ea14894092ed37]
Lucentis (ranibizumab) with conventional treatment
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Mean change in best corrected visual acuity (BCVA) as assessed by the number of letters read correctly on the ETDRS eye chart at a starting test distance of 4 meters from baseline to Month 6. Baseline to Month 6. [clinicaltrials_resource:7aea4f643111e1e688ea14894092ed37]
Lucentis (ranibizumab) with conventional treatment
Bio2RDF identifier
7aea4f643111e1e688ea14894092ed37
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7aea4f643111e1e688ea14894092ed37
measure [clinicaltrials_vocabulary:measure]
Mean change in best corrected ...... ters from baseline to Month 6.
time frame [clinicaltrials_vocabulary:time-frame]
Baseline to Month 6.
description
Lucentis (ranibizumab) with conventional treatment
identifier
clinicaltrials_resource:7aea4f643111e1e688ea14894092ed37
title
Mean change in best corrected ...... Month 6. Baseline to Month 6.
@en
type
label
Mean change in best corrected ...... a4f643111e1e688ea14894092ed37]
@en